Cross-talk between lactate metabolism and immunity reveals CEP55 as a potential regulator in the immunosuppressive microenvironment of hepatocellular carcinoma

Cross-talk between lactate metabolism and immunity reveals CEP55 as a potential regulator in the immunosuppressive microenvironment of hepatocellular carcinoma

Saved in:

Bibliographic Details
Main Authors:	Jie Li, Yuyuan Zhang, Jinhai Deng, Siyuan Weng, Hui Xu, Yuhao Ba, Anning Zuo, Shutong Liu, Quan Cheng, Jian Zhang, Peng Luo, Zhen Li, Xinwei Han, Zaoqu Liu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-05-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S235230422400196X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
by: Dan Shan, et al.
Published: (2025-05-01)

Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential
by: Long Liu, et al.
Published: (2025-04-01)

Total and regional fat-to-muscle mass ratio and risks of pan-cancer: a prospective cohort study
by: Ruizhi Wang, et al.
Published: (2025-05-01)

THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis
by: Zaoqu Liu, et al.
Published: (2025-04-01)

Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
by: Xing Zhou, et al.
Published: (2025-06-01)

THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
by: Xing Zhou, et al.
Published: (2024-12-01)

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
by: Yingying Lv, et al.
Published: (2025-08-01)

Relationship between expression of CEP55 in colorectal cancer tissues and clinicopathological characteristics and prognosis
by: Chen Weili, et al.
Published: (2024-04-01)

CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
by: Murugan Kalimutho, et al.
Published: (2018-08-01)

Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant, and Therapeutic Target?
by: Eugene Y. Kim, et al.
Published: (2025-04-01)

Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
by: Mariarita Spampinato, et al.
Published: (2025-01-01)

Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment
by: Qian Liu, et al.
Published: (2017-06-01)

Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients.
by: Parisa Azimi, et al.
Published: (2025-01-01)

Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients
by: Parisa Azimi, et al.
Published: (2025-01-01)

Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer
by: Kang Lin, et al.
Published: (2021-03-01)

Clinicopathological and prognostic role of CEP55 expression in cancer patients: A meta‐analysis of 31 studies with 12,543 patients
by: Jiangguo Zhang, et al.
Published: (2024-12-01)

An oxygen-generating nanoplatform remodels the immunosuppressive tumor microenvironment via synergistic lactate depletion and sonodynamic therapy
by: Chenchen Tang, et al.
Published: (2025-06-01)

RL4CEP: reinforcement learning for updating CEP rules
by: Afef Mdhaffar, et al.
Published: (2025-01-01)

Research progress of the immunosuppressive tumor microenvironment in multiple myeloma
by: Yue WANG, et al.
Published: (2025-08-01)

Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
by: Jun Yang, et al.
Published: (2025-04-01)

Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma
by: Yang Peng, et al.
Published: (2025-03-01)

Core competency frameworks for the education of pharmacists in Türkiye: EczÇEP-2015 and EczÇEP-2019
by: Yusuf Öztürk, et al.
Published: (2025-05-01)

Crizotinib: A Novel Strategy to Reverse Immunosuppression in Melanoma by Targeting Lactate Transport
by: Zhe Zhou, et al.
Published: (2025-08-01)

Gemcitabine: immunomodulatory or immunosuppressive role in the tumor microenvironment
by: Mahnaz Nemati, et al.
Published: (2025-04-01)

Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
by: Dongxin Jiang, et al.
Published: (2025-05-01)

Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice
by: Min Liu, et al.
Published: (2025-01-01)

The immunosuppressive role of VSIG4 in colorectal cancer and its interaction with the tumor microenvironment
by: H. G. Zhang, et al.
Published: (2025-05-01)

ALKBH5 activates CEP55 transcription through m6A demethylation in FOXP2 mRNA and expedites cell cycle entry and EMT in ovarian cancer
by: Junhui Yu, et al.
Published: (2024-11-01)

PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer
by: Mengdie Cao, et al.
Published: (2025-05-01)

Extracellular vesicles: messengers of cross-talk between gastric cancer cells and the tumor microenvironment
by: Xiwen Li, et al.
Published: (2025-04-01)

Author Correction: Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice
by: Min Liu, et al.
Published: (2025-03-01)

Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD.
by: Yifan Kong, et al.
Published: (2024-06-01)

Editorial: The immunosuppressive microenvironment in pediatric cancers: applications and considerations in immunotherapy
by: Jiaxiong Tan, et al.
Published: (2025-03-01)

Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets
by: Da Pan, et al.
Published: (2025-05-01)

Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis
by: Xiaowei Liu, et al.
Published: (2025-06-01)

VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Li-Guo Chen, et al.
Published: (2025-02-01)

IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment
by: Gilbert Aaron Lee, et al.
Published: (2025-03-01)

OSBPL3 modulates the immunosuppressive microenvironment and predicts therapeutic outcomes in pancreatic cancer
by: Qihui Sun, et al.
Published: (2025-01-01)

Rbfox3 Promotes Transformation of MDSC‐Like Tumor Cells to Shape Immunosuppressive Microenvironment
by: Zhiyang Li, et al.
Published: (2025-02-01)

The influence of microbiome‐derived amino acids metabolites in shaping the glioma immunosuppressive microenvironment
by: Qianquan Ma, et al.
Published: (2025-05-01)